Kirkland Represents GI Partners Fund VI on Acquisition of Clinical Ink Alongside Ardan Equity
October 21, 2026
October 21, 2026
CHICAGO, Illinois, Oct. 21 [Category: BizLaw/Legal] -- Kirkland and Ellis, a law firm, posted the following news release:
* * *
Kirkland Represents GI Partners Fund VI on Acquisition of Clinical Ink Alongside Ardan Equity
*
Kirkland & Ellis advised GI Partners Fund VI on its acquisition of Clinical Ink, Inc., a global clinical trial technology company, alongside Ardan Equity, a private equity firm specializing in healthcare technology. Draw . . .
* * *
Kirkland Represents GI Partners Fund VI on Acquisition of Clinical Ink Alongside Ardan Equity
*
Kirkland & Ellis advised GI Partners Fund VI on its acquisition of Clinical Ink, Inc., a global clinical trial technology company, alongside Ardan Equity, a private equity firm specializing in healthcare technology. Draw . . .